CoChat

Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant

Open access

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Abstract

Ribonuclease L (RNase L) is an important effector of the innate antiviral response. Mutations or variants that impair function of RNase L, particularly R462Q, have been proposed as susceptibility factors for prostate cancer. Given the role of this gene in viral defense, we sought to explore the possibility that a viral infection might contribute to prostate cancer in individuals harboring the R462Q variant. A viral detection DNA microarray composed of oligonucleotides corresponding to the most conserved sequences of all known viruses identified the presence of gammaretroviral sequences in cDNA samples from seven of 11 R462Q-homozygous (QQ) cases, and in one of eight heterozygous (RQ) and homozygous wild-type (RR) cases. An expanded survey of 86 tumors by specific RT-PCR detected the virus in eight of 20 QQ cases (40%), compared with only one sample (1.5%) among 66 RQ and RR cases. The full-length viral genome was cloned and sequenced independently from three positive QQ cases. The virus, named XMRV, is closely related to xenotropic murine leukemia viruses (MuLVs), but its sequence is clearly distinct from all known members of this group. Comparison of gag and pol sequences from different tumor isolates suggested infection with the same virus in all cases, yet sequence variation was consistent with the infections being independently acquired. Analysis of prostate tissues from XMRV-positive cases by in situ hybridization and immunohistochemistry showed that XMRV nucleic acid and protein can be detected in about 1% of stromal cells, predominantly fibroblasts and hematopoietic elements in regions adjacent to the carcinoma. These data provide to our knowledge the first demonstration that xenotropic MuLV-related viruses can produce an authentic human infection, and strongly implicate RNase L activity in the prevention or clearance of infection in vivo. These findings also raise questions about the possible relationship between exogenous infection and cancer development in genetically susceptible individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.0020025This paper is marked retracted.

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Research works printed but not linked: 1

  1. CoffinJMHughesSHVarmusHE 1997 Retroviruses Cold Spring Harbor (New York) Cold Spring Harbor Laboratory Press 843 p.

Cited by

See all 577

Metadata

Authors
Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., Silverman, R. H., & DeRisi, J. L.
Affiliations
  • University of California, San Francisco (US)
  • Cleveland State University (US)
  • Cleveland Clinic (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Silverman, Robert H
  • DeRisi, Joseph L
Venue
PLoS Pathogens
Published
2006-03-31
Volume
2
Issue
3
Pages
e25
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2063905114
Cited by
577
References
83
Citations by year
2024: 3 · 2023: 1 · 2021: 14 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 11 · 2015: 10 · 2014: 24 · 2013: 31 · 2012: 69
FWCI
18.97
Type
journal article
Language
en
Status
Retracted
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Cleveland State University
  • Cleveland Clinic
  • Cleveland Clinic Foundation
  • National Institutes of Health
  • Genentech
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases (R15AI089518)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
Keywords
XMRV, gammaretrovirus, prostate cancer, ribonuclease L, xenotropic murine leukemia virus, genetic susceptibility to cancer, antiviral innate immunity, viral infection and cancer, stromal cells, fibroblasts, tumor microenvironment
MeSH terms
Adenocarcinoma, Amino Acid Sequence, DNA, Viral, Endoribonucleases, Homozygote, Humans, Immunohistochemistry, Male, Molecular Sequence Data, Prostatic Neoplasms, Biomarkers, Tumor, Genome, Viral, In Situ Hybridization, Gammaretrovirus, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant. https://app.cochat.ai/papers/10.1371/journal.ppat.0020025
The paper
Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., Silverman, R. H., & DeRisi, J. L. (2006). Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.0020025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.